Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mark G Kris William Pao |
| Publication date | January 19, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |